Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2007 1
2008 1
2009 2
2010 2
2011 7
2012 8
2013 6
2014 5
2015 7
2016 5
2017 4
2018 3
2019 8
2020 6
2021 12
2022 11
2023 13
2024 12
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Advances in Antibody Design.
Tiller KE, Tessier PM. Tiller KE, et al. Among authors: tessier pm. Annu Rev Biomed Eng. 2015;17:191-216. doi: 10.1146/annurev-bioeng-071114-040733. Epub 2015 Aug 14. Annu Rev Biomed Eng. 2015. PMID: 26274600 Free PMC article. Review.
Assessing developability early in the discovery process for novel biologics.
Fernández-Quintero ML, Ljungars A, Waibl F, Greiff V, Andersen JT, Gjølberg TT, Jenkins TP, Voldborg BG, Grav LM, Kumar S, Georges G, Kettenberger H, Liedl KR, Tessier PM, McCafferty J, Laustsen AH. Fernández-Quintero ML, et al. Among authors: tessier pm. MAbs. 2023 Jan-Dec;15(1):2171248. doi: 10.1080/19420862.2023.2171248. MAbs. 2023. PMID: 36823021 Free PMC article. Review.
Editorial overview: Nanobiotechnology.
Tessier PM, Kane RS. Tessier PM, et al. Curr Opin Biotechnol. 2022 Dec;78:102824. doi: 10.1016/j.copbio.2022.102824. Epub 2022 Nov 10. Curr Opin Biotechnol. 2022. PMID: 36371894 No abstract available.
Engineering aggregation-resistant antibodies.
Perchiacca JM, Tessier PM. Perchiacca JM, et al. Among authors: tessier pm. Annu Rev Chem Biomol Eng. 2012;3:263-86. doi: 10.1146/annurev-chembioeng-062011-081052. Epub 2012 Mar 29. Annu Rev Chem Biomol Eng. 2012. PMID: 22468604 Review.
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs.
Pornnoppadol G, Bond LG, Lucas MJ, Zupancic JM, Kuo YH, Zhang B, Greineder CF, Tessier PM. Pornnoppadol G, et al. Among authors: tessier pm. bioRxiv [Preprint]. 2023 Apr 29:2023.04.29.538811. doi: 10.1101/2023.04.29.538811. bioRxiv. 2023. Update in: Cell Chem Biol. 2024 Feb 15;31(2):361-372.e8. doi: 10.1016/j.chembiol.2023.09.008. PMID: 37162883 Free PMC article. Updated. Preprint.
Engineered Autonomous Human Variable Domains.
Nilvebrant J, Tessier PM, Sidhu SS. Nilvebrant J, et al. Among authors: tessier pm. Curr Pharm Des. 2016;22(43):6527-6537. doi: 10.2174/1381612822666160921143011. Curr Pharm Des. 2016. PMID: 27655414 Free PMC article. Review.
Improving antibody drug development using bionanotechnology.
Makowski EK, Schardt JS, Tessier PM. Makowski EK, et al. Among authors: tessier pm. Curr Opin Biotechnol. 2022 Apr;74:137-145. doi: 10.1016/j.copbio.2021.10.027. Epub 2021 Dec 7. Curr Opin Biotechnol. 2022. PMID: 34890875 Free PMC article. Review.
109 results